ESR1 and ductal breast carcinoma in situ: JuP3 showed a 1.5 cm estrogen receptor (ER)‐positive/HER2‐negative moderately‐differentiated IDC‐NST and DCIS with intermediate to high nuclear grade and necrosis that was intimately associated with benign JP components (Figure 2A–D).